Transderm Nitro (Nitroglycerin Transdermal) - Summary

SUMMARY

Transderm Nitro^®

Nitroglycerin is 1,2,3-propanetriol, trinitrate, an organic nitrate.

Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of transdermal nitroglycerin is not sufficiently rapid for this product to be useful in aborting an acute attack.

See all Transderm Nitro indications & dosage >>

NEWS HIGHLIGHTS RELATED TO TRANSDERM NITRO

Published Studies Related to Transderm Nitro (Nitroglycerin Transdermal)

The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. [2008.10]

Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial. [2008.08]

Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe pre-eclampsia: a randomized, triple-blind, controlled trial. [2008.05]

The effect of intravenous nitroglycerine on blood pressure during intubation. [2008.02]

Effects of sublingual nitroglycerin on coronary lumen diameter and number of visualized septal branches on 64-MDCT angiography. [2008.01]

more >>

Clinical Trials Related to Transderm Nitro (Nitroglycerin Transdermal)

Scopolamine to Treat Depression

Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies [Recruiting]

more >>